Page 202 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 202

192        ELECTROLYTE DISORDERS



            537. Silver J, Naveh-Many T. Vitamin D and the parathyroid  557. Taylor MB, Geiger DA, Saker KE, Larson MM. Diffuse
                 glands. In: Feldman D, editor. Vitamin D. San Diego:  osteopenia and myelopathy in a puppy fed a diet com-
                 Academic Press; 1997. p. 353–367.                   posed of an organic premix and raw ground beef. J Am
            538. Silver J, Yalcindag C, Sela-Brown A, et al. Regulation of  Vet Med Assoc 2009;234(8):1041–8.
                 the parathyroid hormone gene by vitamin D, calcium  558. Teare JA, Krook L, Kallfelz FA, et al. Ascorbic acid
                 and phosphate. Kidney Int Suppl 1999;73:S2–S7.      deficiency and hypertrophic osteodystrophy in the dog:
            539. Slatopolsky E, Finch J, Brown A. New vitamin D analogs.  a rebuttal. Cornell Vet 1979;69:384–401.
                 Kidney Int Suppl 2003;85:S83–17.                559. Tebb AJ, Arteaga A, Evans H, Ramsey IK. Canine
            540. Slatopolsky E, Lopez-Hilker S, Delmez J, et al. The para-  hyperadrenocorticism: effects of trilostane on parathyroid
                 thyroid-calcitriol axis in health and chronic renal failure.  hormone, calcium and phosphate concentrations. J Small
                 Kidney Int Suppl 1990;29:S41–7.                     Anim Pract 2005;46(11):537–42.
            541. Smith SA, Freeman LC, Bagladi-Swanson M. Hypercalce-  560. Terry AH, Orrock J, Meikle AW. Comparison of two
                 mia due to iatrogenic secondary hypoadrenocorticism and  third-generation parathyroid hormone assays. Clin Chem
                 diabetes mellitus in a cat. J Am Anim Hosp Assoc    2003;49:336–7.
                 2002;38:41–4.                                   561. Teske E, van Heerde P, Rutteman GR, et al. Prognostic
            542. Smock SL, Vogt GA, Castleberry TA, et al. Molecular  factors for treatment of malignant lymphoma in dogs.
                 cloning and functional characterization of the canine para-  J Am Vet Med Assoc 1994;205:1722–8.
                 thyroid hormone/parathyroid hormone related peptide  562. Tfelt-Hansen J, Chattopadhyay N, Yano S, et al. Calcium-
                 receptor (PTH1). Mol Biol Rep 2001;28:235–43.       sensing receptor induces proliferation through p38
            543. Sprague SM, Coyne D. Control of secondary hyperpara-  mitogen-activated protein kinase and phosphatidy-
                 thyroidism by Vitamin D receptor agonists in chronic kid-  linositol 3-kinase but not extracellularly regulated kinase
                 ney disease. Clin J Am Soc Nephrol 2010;5:512–8.    in a model of humoral hypercalcemia of malignancy.
            544. St. Arnaud R, Glorieux FH. Vitamin D and bone develop-  Endocrinology 2004;145:1211–7.
                 ment. In: Feldman D, editor. Vitamin D. San Diego: Aca-  563. Thadhani R. Is calcitriol life-protective for patients with
                 demic Press; 1997. p. 293–303.                      chronic  kidney  disease?  J  Am.  Soc  Nephrol
            545. Stern PH. Vitamin D and bone. Kidney Int Suppl      2009;20:2285–90.
                 1990;29:S17–S21.                                564. Thakker RV. Diseases associated with the extracellular cal-
            546. Stevens LA, Djurdjev O, Cardew S, et al. Calcium, phos-  cium-sensing receptor. Cell Calcium 2004;35:275–82.
                 phate, and parathyroid hormone levels in combination  565. Thiede MA, Daifotis AG, Weir EC, et al. Intrauterine
                 and as a function of dialysis duration predict mortality:  occupancy controls expression of the parathyroid hor-
                 evidence for the complexity of the association between  mone-related peptide gene in preterm rat myometrium.
                 mineral metabolism and outcomes. J Am Soc Nephrol   Proc Natl Acad Sci USA 1990;87:6969–73.
                 2004;15:770–9.                                  566. Thode J, Juul-Jorgensen B, Bhatia HM, et al. Comparison
            547. Storms TN, Clyde VL, Munson L, et al. Blastomycosis in  of serum total calcium, albumin-corrected total calcium,
                 nondomestic felids. J Zoo Wildl Med 2003;34:231–8.  and ionized calcium in 1213 patients with suspected cal-
            548. Strewler GJ. Physiological actions of PTH and PTHrP:  cium disorders. Scand J Clin Lab Invest 1989;49:217–23.
                 Skeletal  actions.  In:  Bilezikian  JP,  Marcus  R,  567. Thomasset M. Calbindin-D 9K. In: Feldman D, editor.
                 Levine MA, editors. The parathyroids. San Diego: Aca-  Vitamin D. New York: Academic Press; 1997. p. 223–232.
                 demic Press; 2001. p. 213–226.                  568. Thompson KG, Jones LP, Smylie WA, et al. Primary hyper-
            549. Suda T, Takahashi N. Vitamin D and osteoclastogenesis.  parathyroidism in German shepherd dogs: a disorder of
                 In: Feldman D, editor. Vitamin D. San Diego: Academic  probable genetic origin. Vet Pathol 1984;21:370–6.
                 Press; 1997. p. 329–340.                        569. Thrall MA, Grauer GF, Mero KN. Clinicopathologic
            550. Sueda MT, Stefanacci JD. Ultrasound evaluation of the  findings in dogs and cats with ethylene glycol intoxication.
                 parathyroid glands in two hypercalcemic cats. Vet Radiol  J Am Vet Med Assoc 1984;184:37–41.
                 Ultrasound 2000;41:448–51.                      570. Thurlimann B, Waldburger R, Senn HJ, et al. Plicamycin
            551. Suva LJ, Winslow GA, Wettenhall RE, et al. A parathyroid  and pamidronate in symptomatic tumor-related hypercal-
                 hormone-related protein implicated in malignant hypercal-  cemia: a prospective randomized crossover trial. Ann
                 cemia: cloning and expression. Science 1987;237:893–6.  Oncol 1992;3:619–23.
            552. Swarthout JT, D’Alonzo RC, Selvamurugan N, et al.  571. Toffaletti J. Ionized calcium measurement: analytical and
                 Parathyroid hormone-dependent signaling pathways    clinical aspects. Lab Management 1983;(July):31–5.
                 regulating genes in bone cells. Gene 2002;282:1–17.  572. Tohme JF, Bilezikian JP. Hypocalcemic emergencies.
            553. Szenci O, Brydl E, Bajcsy CA. Effect of storage on mea-  Endocrinol Metab Clin North Am 1993;22:363–75.
                 surement of ionized calcium and acid-base variables in  573. Tomsa K, Glaus T, Hauser B, et al. Nutritional secondary
                 equine, bovine, ovine, and canine venous blood. J Am  hyperparathyroidism in six cats. J Small Anim Pract
                 Vet Med Assoc 1991;199:1167–9.                      1999;40:533–9.
            554. Takahashi HE, Tanizawa T, Hori M, et al. Effect of inter-  574. Tomsa K, Steffen F, Glaus T. Life threatening metabolic
                 mittent administration of human parathyroid hormone  disorders after application of a sodium phosphate
                 (1-34) on experimental osteopenia of rats induced by  containing enema in the dog and cat. Schweiz Arch
                 ovariectomy. Cell Mater 1991;113–7.                 Tierheilkd 2001;143:257–61.
            555. Tannehill-Gregg S, Kergosien E, Rosol TJ. Feline head  575. Toribio RE, Kohn CW, Chew DJ, et al. Comparison
                 and neck squamous cell carcinoma cell line: characteriza-  of serum parathyroid hormone and ionized calcium
                 tion, production of parathyroid hormone-related protein,  and magnesium concentrations and fractional urinary
                 and regulation by transforming growth factor-beta. In  clearance of calcium and phosphorus in healthy horses
                 Vitro Cell Dev Biol Anim 2001;37:676–83.            and  horses  with  enterocolitis.  Am  J  Vet  Res
            556. Tanner E, Langley-Hobbs SJ. Vitamin D-dependent rick-  2001;62:938–47.
                 ets type 2 with characteristic radiographic changes in a 4-  576. Torley D, Drummond A, Bilsland DJ. Calcipotriol toxic-
                 month-old kitten. J Feline Med Surg 2005;7(5):307–11.  ity in dogs. Br J Dermatol 2002;147:1270.
   197   198   199   200   201   202   203   204   205   206   207